Volume 28, Issue 166 (11-2018)                   J Mazandaran Univ Med Sci 2018, 28(166): 10-20 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Nemati Mansoor F, Bashash D. Cytotoxic Effect of Telomerase Catalytic (hTERT) and Nucleotide (hTERC) Subunit Inhibitors on Acute Promyelocytic Leukemia Cells. J Mazandaran Univ Med Sci. 2018; 28 (166) :10-20
URL: http://jmums.mazums.ac.ir/article-1-10515-en.html
Abstract:   (865 Views)

Background and purpose: Telomerase activity has a major role in acute promyelocytic leukemia (APL). It also has a critical role in disease recurrence. This research aimed at studying the cytotoxic effects of telomerase inhibition using oligonucleotide-based molecule against human telomerase RNA template (hTERC antisense) and non-nucleoside small molecule targeting catalytic subunit (BIBR5132) on APL-derived cell line.
Materials and methods: To evaluate whether inhibition of telomerase using either hTERC antisense or BIBR5132 could exert cytotoxic effect in APL, NB4 cells were subjected to different concentrations of the inhibitors and subsequent cell viability, metabolic activity, induction of apoptosis were investigated using Trypan blue assay, MTT, and annexin/PI staining, respectively. Also, Caspase-3 enzymatic activity and transcriptional alteration of apoptosis-related target genes were investigated.
Results: We found that targeting telomerase using hTERC antisense (45 pmol/L) and BIBR1532 (75 µL) for 48 h reduced the survival rate of NB4 cells nearly by 30% and 40%, respectively and induced a caspase-3-dependent apoptosis. Our results also suggest that suppression of c-Myc and subsequent increment of Bax/Bcl-2 ratio coupled with decreased telomerase activity may be rational mechanisms for the cytotoxicity of both telomerase inhibitors against NB4 cells.
Conclusion: Current results clearly indicated that both BIBR1532 and hTERC antisense had anti-tumor activity against NB4 cells and anti-telomerase-based therapy may be an efficient treatment for acute promyelocytic leukemia.

Full-Text [PDF 876 kb]   (226 Downloads)    

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb